Literature DB >> 26210850

Reliability of the modified Gross Motor Function Measure-88 (GMFM-88) for children with both Spastic Cerebral Palsy and Cerebral Visual Impairment: A preliminary study.

M Salavati1, W P Krijnen2, E A A Rameckers3, P L Looijestijn4, C G B Maathuis5, C P van der Schans6, B Steenbergen7.   

Abstract

PURPOSE: The aims of this study were to adapt the Gross Motor Function Measure-88 (GMFM-88) for children with Cerebral Palsy (CP) and Cerebral Visual Impairment (CVI) and to determine the test-retest and interobserver reliability of the adapted version.
METHOD: Sixteen paediatric physical therapists familiar with CVI participated in the adaptation process. The Delphi method was used to gain consensus among a panel of experts. Seventy-seven children with CP and CVI (44 boys and 33 girls, aged between 50 and 144 months) participated in this study. To assess test-retest and interobserver reliability, the GMFM-88 was administered twice within three weeks (Mean=9 days, SD=6 days) by trained paediatric physical therapists, one of whom was familiar with the child and one who wasn't. Percentages of identical scores, Cronbach's alphas and intraclass correlation coefficients (ICC) were computed for each dimension level.
RESULTS: All experts agreed on the proposed adaptations of the GMFM-88 for children with CP and CVI. Test-retest reliability ICCs for dimension scores were between 0.94 and 1.00, mean percentages of identical scores between 29 and 71, and interobserver reliability ICCs of the adapted GMFM-88 were 0.99-1.00 for dimension scores. Mean percentages of identical scores varied between 53 and 91. Test-retest and interobserver reliability of the GMFM-88-CVI for children with CP and CVI was excellent. Internal consistency of dimension scores lay between 0.97 and 1.00.
CONCLUSION: The psychometric properties of the adapted GMFM-88 for children with CP and CVI are reliable and comparable to the original GMFM-88.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CP; CVI; Children; GMFM-88

Mesh:

Year:  2015        PMID: 26210850     DOI: 10.1016/j.ridd.2015.07.013

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  6 in total

1.  Efficacy of Supporting Play Exploration and Early Development Intervention in the First Months of Life for Infants Born Very Preterm: 3-Arm Randomized Clinical Trial Protocol.

Authors:  Stacey C Dusing; Jennifer C Burnsed; Shaaron E Brown; Amy D Harper; Karen D Hendricks-Munoz; Richard D Stevenson; Leroy R Thacker; Rebecca M Molinini
Journal:  Phys Ther       Date:  2020-08-12

2.  Efficacy of microsurgery for congenital neural tube defects in newborns.

Authors:  Cuicui Li; Bingbing Gao; Hepu Lin; Yunjun Li; Bo Xiu; Yiwu Dai
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

3.  Treatment response prediction of rehabilitation program in children with cerebral palsy using radiomics strategy: protocol for a multicenter prospective cohort study in west China.

Authors:  Heng Liu; Haoxiang Jiang; Xiaoyu Wang; Jie Zheng; Huifang Zhao; Yannan Cheng; Xingxing Tao; Miaomiao Wang; Congcong Liu; Ting Huang; Liang Wu; Chao Jin; Xianjun Li; Hui Wang; Jian Yang
Journal:  Quant Imaging Med Surg       Date:  2019-08

4.  Effects of combined Adeli suit and neurodevelopmental treatment in children with spastic cerebral palsy with gross motor function classification system levels I and II.

Authors:  Mi-Ra Kim; Byoung-Hee Lee; Dae-Sung Park
Journal:  Hong Kong Physiother J       Date:  2015-11-07

5.  Effects of Task-oriented Activities Based on Neurodevelopmental Therapy Principles on Trunk Control, Balance, and Gross Motor Function in Children with Spastic Diplegic Cerebral Palsy: A Single-blinded Randomized Clinical Trial.

Authors:  Ajaya K Sah; Gandhi Karunanithi Balaji; Sahana Agrahara
Journal:  J Pediatr Neurosci       Date:  2019-09-27

Review 6.  What assessments are currently used to investigate and diagnose cerebral visual impairment (CVI) in children? A systematic review.

Authors:  Emma L McConnell; Kathryn J Saunders; Julie-Anne Little
Journal:  Ophthalmic Physiol Opt       Date:  2020-12-27       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.